Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease

To investigate the effect of antidiabetic agents on nonalcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM), 75 patients with T2DM and NAFLD under inadequate glycemic control by metformin were randomized (1:1:1) to receive add‐on liraglutide, sitagliptin, or insulin...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Hepatology
Main Authors: Yan, Jinhua, Yao, Bin, Kuang, Hongyu, Yang, Xubin, Huang, Qin, Hong, Tianpei, Li, Yushu, Dou, Jingtao, Yang, Wenying, Qin, Guijun, Yuan, Huijuan, Xiao, Xinhua, Luo, Sihui, Shan, Zhongyan, Deng, Hongrong, Tan, Ying, Xu, Fen, Xu, Wen, Zeng, Longyi, Kang, Zhuang, Weng, Jianping
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley and Sons Inc. 2019
נושאים:
Original Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6594101/
https://ncbi.nlm.nih.gov/pubmed/30341767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.30320
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים